TVARDI THERAPEUTICS, INC. (TVRD) Net income 2016–2025
TVARDI THERAPEUTICS, INC. (TVRD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$18.2MFY2025 · since FY2016: -$57.3M → -$18.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.2M | +38.0% |
| FY2024 | -$29.4M | +75.2% |
| FY2023 | -$118.5M | -38.7% |
| FY2022 | -$85.5M | +3.4% |
| FY2021 | -$88.4M | -1151.6% |
| FY2020 | $8.4M | +107.9% |
| FY2019 | -$106.4M | -43.7% |
| FY2018 | -$74.0M | -27.3% |
| FY2017 | -$58.1M | -1.5% |
| FY2016 | -$57.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net marginTVRD Gross profitTVRD Gross marginTVRD Operating incomeTVRD Operating marginTVRD Operating cash flowTVRD Free cash flowTVRD Capital expendituresTVRD Return on equityTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Total liabilitiesTVRD Shareholders’ equityTVRD overview →